STS
NVO

SG Trading Solutions’s Novo Nordisk NVO Stock Holding History

SG Trading Solutions’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$401K Buy
+7,875
New +$403K 0.09% 163

Other funds holding NVO

Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

SG Trading Solutions's NVO Position: Q4 2025 in Review

SG Trading Solutions opened a new position in Novo Nordisk (NVO) in Q4 2025: 7,875 shares worth $401K. The stake represents 0.09% of the portfolio and ranks #163 among its holdings.

1,418 funds tracked by Wall St. Rank hold NVO as of Q4 2025.

  • SG Trading Solutions held 7,875 shares of Novo Nordisk worth $401K as of Q4 2025.
  • Novo Nordisk was a new SG Trading Solutions position in Q4 2025.
  • Novo Nordisk made up 0.09% of SG Trading Solutions's portfolio in Q4 2025, its #163 holding.
  • 1,418 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2025.

Based on SG Trading Solutions's 13F filing for Q4 2025, filed 24 Feb 2026.